Verification Trials Can Create the Illusion of VO2max in Addition to Contributing to Its Confirmation

dc.contributor.author Cabuk, Refik
dc.contributor.author Alp, Egemen
dc.contributor.author Murias, Juan Manuel
dc.contributor.author Karsten, Bettina
dc.date.accessioned 2026-03-12T14:36:01Z
dc.date.available 2026-03-12T14:36:01Z
dc.date.issued 2026
dc.description Alp, Egemen/0000-0002-5915-8625 en_US
dc.description.abstract This study examined whether constant-workload verification trials performed at intensities below, at, and above the ramp-incremental peak power output (PPO) contribute to confirming maximal oxygen uptake (VO2max). Fifteen trained to well-trained male cyclists (VO2max: 63.6 +/- 5.6 mL & centerdot;kg(-1)& centerdot;min(-1)) completed maximal ramp testing followed by seven randomized verification trials (80%-110% PPO at 5% intervals) on separate days. Differences in VO2 responses were analyzed using linear mixed-effects models. Effect size was calculated using Hedges' g. The peak VO2 attained during the verification trials was expressed relative to the ramp-derived VO2max and classified as lower (< 95%), within normal variability (95%-105%), or higher (> 105%). The peak VO2 values at 80%, 105%, and 110% PPO were significantly lower than ramp-derived VO2max (p < 0.05), whereas no significant differences were observed at 85%, 90%, and 95% PPO. Effect sizes were small at 85%-95% PPO (Hedges' g = 0.29-0.32), medium at 100%-105% PPO (Hedges' g = 0.63-0.66), and large at 80% and 110% PPO (Hedges' g = 1.21-1.34). Of 105 verification trials, 81 were within +/- 5% of ramp VO2max, 22 were lower (mainly at 80% and 110% PPO), and two exceeded ramp VO2max (at 85% and 95% PPO). Although verification trials did not meaningfully contribute to the verification of VO2max, trials performed at 85%-95% PPO provided the best chances of confirming VO2max in trained individuals. Interpretation of verification trials relative to ramp-derived PPO is protocol dependent, which may limit generalizability across different ramp designs. en_US
dc.identifier.doi 10.1111/sms.70226
dc.identifier.issn 0905-7188
dc.identifier.issn 1600-0838
dc.identifier.scopus 2-s2.0-105030491823
dc.identifier.uri https://doi.org/10.1111/sms.70226
dc.identifier.uri https://hdl.handle.net/20.500.14627/1436
dc.language.iso en en_US
dc.publisher Wiley en_US
dc.relation.ispartof Scandinavian Journal of Medicine & Science in Sports en_US
dc.rights info:eu-repo/semantics/closedAccess en_US
dc.subject Aerobic Capacity en_US
dc.subject Cardiopulmonary Exercise Testing en_US
dc.subject Constant-Workload Trials en_US
dc.subject Peak Oxygen Uptake en_US
dc.subject Ramp-Incremental Test en_US
dc.subject Severe-Intensity Domain en_US
dc.title Verification Trials Can Create the Illusion of VO2max in Addition to Contributing to Its Confirmation en_US
dc.type Article en_US
dspace.entity.type Publication
gdc.author.id Alp, Egemen/0000-0002-5915-8625
gdc.author.scopusid 57397716700
gdc.author.scopusid 60404270800
gdc.author.scopusid 14623024100
gdc.author.scopusid 55848078400
gdc.author.wosid Murias, Juan/Hrc-2758-2023
gdc.author.wosid Cabuk, Refik/Aha-8309-2022
gdc.description.department Fenerbahçe University en_US
gdc.description.departmenttemp [Cabuk, Refik] Ondokuz Mayis Univ, Yasar Dogu Fac Sport Sci, Dept Coaching Educ, Samsun, Turkiye; [Cabuk, Refik; Murias, Juan Manuel] Hamad Bin Khalifa Univ, Coll Hlth & Life Sci, Doha, Qatar; [Alp, Egemen] Fenerbahce Univ, Fac Sports Sci, Dept Exercise & Sports Sci, Istanbul, Turkiye; [Karsten, Bettina] Univ Greenwich, Inst Lifecourse Dev, Ctr Exercise Act & Rehabil, Sch Human Sci, London, England; [Karsten, Bettina] CBS Univ Appl Sci, Fac Hlth & Pedag, Cologne, Germany en_US
gdc.description.issue 2 en_US
gdc.description.publicationcategory Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı en_US
gdc.description.scopusquality Q1
gdc.description.volume 36 en_US
gdc.description.woscitationindex Science Citation Index Expanded
gdc.description.wosquality Q1
gdc.identifier.openalex W7130433732
gdc.identifier.pmid 41707053
gdc.identifier.wos WOS:001694759200001
gdc.index.type WoS
gdc.index.type Scopus
gdc.index.type PubMed
gdc.openalex.fwci 0.0
gdc.openalex.normalizedpercentile 0.71
gdc.plumx.scopuscites 0
gdc.scopus.citedcount 0
gdc.virtual.author Alp, Egemen
gdc.wos.citedcount 0
relation.isAuthorOfPublication d7c6f388-604b-4e11-9e8e-93113b862e66
relation.isAuthorOfPublication.latestForDiscovery d7c6f388-604b-4e11-9e8e-93113b862e66

Files